300 filings
Page 3 of 15
424B3
ITOS
ITeos Therapeutics Inc
19 May 23
Prospectus supplement
4:14pm
CORRESP
ITOS
ITeos Therapeutics Inc
17 May 23
Correspondence with SEC
12:00am
UPLOAD
ITOS
ITeos Therapeutics Inc
15 May 23
Letter from SEC
12:00am
S-3
ITOS
ITeos Therapeutics Inc
10 May 23
Shelf registration
7:52am
10-Q
2023 Q1
ITOS
ITeos Therapeutics Inc
Quarterly report
10 May 23
7:09am
ARS
2022 FY
ITOS
ITeos Therapeutics Inc
27 Apr 23
Annual report to shareholders
7:14am
DEFA14A
ITOS
ITeos Therapeutics Inc
27 Apr 23
Additional proxy soliciting materials
7:09am
DEF 14A
ITOS
ITeos Therapeutics Inc
Definitive proxy
27 Apr 23
7:05am
4
Matthew Call
29 Mar 23
iTeos Therapeutics / Matthew Call ownership change
8:00pm
S-8
ITOS
ITeos Therapeutics Inc
15 Mar 23
Registration of securities for employees
7:13am
10-K
2022 FY
ITOS
ITeos Therapeutics Inc
Annual report
15 Mar 23
7:05am
4
Yvonne McGrath
10 Mar 23
iTeos Therapeutics / Yvonne McGrath ownership change
7:54pm
4
Joanne Jenkins Lager
10 Mar 23
iTeos Therapeutics / Joanne Jenkins Lager ownership change
7:53pm
4
ITOS
ITeos Therapeutics Inc
10 Mar 23
iTeos Therapeutics / Matthew Gall ownership change
7:53pm
4
Matthew Call
10 Mar 23
iTeos Therapeutics / Matthew Call ownership change
7:52pm
4
Michel Detheux
10 Mar 23
iTeos Therapeutics / Michel Detheux ownership change
7:51pm
5
Michel Detheux
10 Mar 23
iTeos Therapeutics / Michel Detheux ownership change
7:50pm
8-K
ITOS
ITeos Therapeutics Inc
10 Mar 23
Regulation FD Disclosure
5:19pm
SC 13G/A
ITOS
ITeos Therapeutics Inc
14 Feb 23
iTeos Therapeutics / RTW INVESTMENTS ownership change
10:08am
SC 13G/A
Biotechnology Value Fund L P
14 Feb 23
iTeos Therapeutics / BIOTECHNOLOGY VALUE FUND L P ownership change
12:00am